Compare, Analyse NATURAL CAPS with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATURAL CAPS vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NATURAL CAPS   ADCOCK INGRAM
EQUITY SHARE DATA
    NATURAL CAPS
Mar-21
ADCOCK INGRAM
Jun-14
NATURAL CAPS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs140344-   
Low Rs34248-   
Sales per share (Unadj.) Rs127.6102.2-  
Earnings per share (Unadj.) Rs11.1-25.8-  
Cash flow per share (Unadj.) Rs18.0-21.3-  
Dividends per share (Unadj.) Rs1.000-  
Avg Dividend yield %1.10-  
Book value per share (Unadj.) Rs99.780.2-  
Shares outstanding (eoy) m6.23168.78-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.72.9 23.6%   
Avg P/E ratio x7.9-11.5 -68.5%  
P/CF ratio (eoy) x4.8-13.9 -35.0%  
Price / Book Value ratio x0.93.7 23.7%  
Dividend payout %9.00-   
Avg Mkt Cap Rs m54449,921 1.1%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m703,133 2.2%   
Avg. sales/employee Rs ThNM4,019.0-  
Avg. wages/employee Rs ThNM729.8-  
Avg. net profit/employee Rs ThNM-1,012.7-  
INCOME DATA
Net Sales Rs m79517,254 4.6%  
Other income Rs m7121 6.0%   
Total revenues Rs m80217,374 4.6%   
Gross profit Rs m133-2,990 -4.4%  
Depreciation Rs m43745 5.8%   
Interest Rs m5467 1.2%   
Profit before tax Rs m92-4,081 -2.2%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m22255 8.8%   
Profit after tax Rs m69-4,348 -1.6%  
Gross profit margin %16.7-17.3 -96.3%  
Effective tax rate %24.5-6.2 -392.1%   
Net profit margin %8.7-25.2 -34.5%  
BALANCE SHEET DATA
Current assets Rs m41912,637 3.3%   
Current liabilities Rs m3397,110 4.8%   
Net working cap to sales %10.232.0 31.7%  
Current ratio x1.21.8 69.7%  
Inventory Days Days46111 41.5%  
Debtors Days Days122,546,289124 98,875,846.3%  
Net fixed assets Rs m5517,366 7.5%   
Share capital Rs m6280 77.8%   
"Free" reserves Rs m5590-   
Net worth Rs m62113,542 4.6%   
Long term debt Rs m04,759 0.0%   
Total assets Rs m97025,582 3.8%  
Interest coverage x17.8-7.7 -230.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.80.7 121.5%   
Return on assets %7.7-15.2 -50.7%  
Return on equity %11.1-32.1 -34.7%  
Return on capital %15.6-19.8 -78.9%  
Exports to sales %17.00-   
Imports to sales %00-   
Net fx Rs m740-   
CASH FLOW
From Operations Rs m1261,473 8.6%  
From Investments Rs m-156-452 34.5%  
From Financial Activity Rs m284,319 0.6%  
Net Cashflow Rs m-25,340 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.74 Rs / ZAR

Compare NATURAL CAPS With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare NATURAL CAPS With: MOREPEN LABS  INDOCO REMEDIES  CONCORD DRUGS  KWALITY PHARMA  GENNEX LAB.  



Today's Market

Sensex Zooms 800 Points, Nifty Tops 17,400; RBI Keeps Repo Rate Unchanged at 4%(10:30 am)

Asian share markets are higher today after Wall Street shares rallied for a second straight session on receding worries over the latest Covid-19 variant.

Related Views On News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

6 Penny Stocks that Rallied 1,000%+ in One Year (Views On News)

Dec 6, 2021

These penny stocks shed their penny status by surging 1,000% or more in the last one year.

The Biggest Winners and Losers in India's Transition to Electric Vehicles (Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

NATURAL CAPS SHARE PRICE


Dec 8, 2021 12:41 PM

TRACK NATURAL CAPS

  • Track your investment in NATURAL CAPS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NATURAL CAPS

NATURAL CAPS 5-YR ANALYSIS

COMPARE NATURAL CAPS WITH

MARKET STATS